When performing the analysis in breast cancer subtypes independently, we recognized sixty-one genes in basal-like tumors, one hundred fifteen genes in HER2 positive tumors, and one hundred thirty-nine and thirty-nine genes in the Luminal A and B subtype, respectively (Fig. 1b, Supplementary Table 2). This evidence concerns the gene ERBB2 and breast cancer.